Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein

Gene Therapy

Volumn 19, Issue 7, 2012, Pages 761-774

  Carpentier, D C J ^a,b   Vevis, K ^a,b   Trabalza, A ^a,b   Georgiadis, C ^a,b   Ellison, S M ^a,b   Asfahani, R I ^c   Mazarakis, N D ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

glycoprotein; lentivirus vectors; pseudotyping; rabies virus; vesicular stomatitis virus

Indexed keywords

CHIMERIC PROTEIN; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL STRAIN HEK293; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC TRANSDUCTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PSEUDOTYPING; RABIES VIRUS; RAT; RETROGRADE NERVE FIBER TRANSPORT; SEQUENCE ALIGNMENT; SUBSTANTIA NIGRA; THALAMUS; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS TYPING;

ANTIGENS, VIRAL; GENETIC VECTORS; GLYCOPROTEINS; HIV-1; MEMBRANE GLYCOPROTEINS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; RABIES VIRUS; RATTUS; RODENTIA; VESICULAR STOMATITIS VIRUS;

EID: 84863722817     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.124     Document Type: Article

References (49)

1. Canivet M, Hoffman AD, Hardy D, Sernatinger J, Levy JA. Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retroviruses. Virology 1990; 178: 543-551. (Pubitemid 20349892)
2. Lusso P, di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRocco SE et al. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 1990; 247: 848-852.
3. Chesebro B, Wehrly K, Maury W. Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses. J Virol 1990; 64: 4553-4557. (Pubitemid 20279870)
4. Spector DH, Wade E, Wright DA, Koval V, Clark C, Jaquish D et al. Human immunodeficiency virus pseudotypes with expanded cellular and species tropism. J Virol 1990; 64: 2298-2308. (Pubitemid 20148478)
5. Zhu ZH, Chen SS, Huang AS. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr 1990; 3: 215-219. (Pubitemid 20116206)
6. Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005; 5: 387-398. (Pubitemid 41052430)
7. Bartz SR, Rogel ME, Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 1996; 70: 2324-2331. (Pubitemid 26087595)
8. Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 2001; 10: 2109-2121. (Pubitemid 32998823)
9. Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Therapy 1999; 6: 1808-1818. (Pubitemid 29531276)
10. Wong LF, Azzouz M, Walmsley LE, Askham Z, Wilkes FJ, Mitrophanous KA et al. Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 2004; 9: 101-111. (Pubitemid 38208333)
11. Mentis GZ, Gravell M, Hamilton R, Shneider NA, O¢Donovan MJ, Schubert M. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins. J Neurosci Methods 2006; 157: 208-217. (Pubitemid 44339638)
12. Kato S, Inoue K, Kobayashi K, Yasoshima Y, Miyachi S, Inoue S et al. Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum Gene Ther 2007; 18: 1141-1151. (Pubitemid 350114690)
13. Federici T, Kutner R, Zhang XY, Kuroda H, Tordo N, Boulis NM et al. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer. Genet Vaccines Ther 2009; 7: 1.
14. Mochizuki H, Schwartz JP, Tanaka K, Brady RO, Reiser J. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 1998; 72: 8873-8883. (Pubitemid 28471831)
15. Abelseth MK. An attenuated rabies vaccine for domestic animals produced in tissue culture. Can Vet J 1964; 5: 279-286.
16. Azzouz M, Le T, Ralph GS, Walmsley L, Monani UR, Lee DC et al. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest 2004; 114: 1726-1731. (Pubitemid 40385528)
17. Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413-417. (Pubitemid 38715132)
18. Ralph GS, Radcliffe PA, Day DM, Carthy JM, Leroux MA, Lee DC et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 2005; 11: 429-433. (Pubitemid 40562334)
19. Wong LF, Goodhead L, Prat C, Mitrophanous KA, Kingsman SM, Mazarakis ND. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 2006; 17: 1-9. (Pubitemid 43102718)
20. Backovic M, Jardetzky TS. Class III viral membrane fusion proteins. Curr Opin Struct Biol 2009; 19: 189-196.
21. Gaudin Y, Ruigrok RW, Tuffereau C, Knossow M, Flamand A. Rabies virus glycoprotein is a trimer. Virology 1992; 187: 627-632.
22. Doms RW, Keller DS, Helenius A, Balch WE. Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers. J Cell Biol 1987; 105: 1957-1969. (Pubitemid 18019047)
23. Roche S, Bressanelli S, Rey FA, Gaudin Y. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 2006; 313: 187-191. (Pubitemid 44066243)
24. Roche S, Rey FA, Gaudin Y, Bressanelli S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007; 315: 843-848.
25. Rose JK, Doolittle RF, Anilionis A, Curtis PJ, Wunner WH. Homology between the glycoproteins of vesicular stomatitis virus and rabies virus. J Virol 1982; 43: 361-364. (Pubitemid 12084918)
26. Roche S, Albertini AA, Lepault J, Bressanelli S, Gaudin Y. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited. Cell Mol Life Sci 2008; 65: 1716-1728.
27. Rose JK, Welch WJ, Sefton BM, Esch FS, Ling NC. Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the COOH terminus. Proc Natl Acad Sci USA 1980; 77: 3884-3888. (Pubitemid 10015485)
28. Warrens AN, Jones MD, Lechler RI. Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene 1997; 186: 29-35. (Pubitemid 27084826)
29. Ganser-Pornillos BK, Yeager M, Sundquist WI. The structural biology of HIV assembly. Curr Opin Struct Biol 2008; 18: 203-217.
30. Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2000; 407: 409-413.
31. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J 2003; 22: 1707-1715. (Pubitemid 36417418)
32. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-2428.
33. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 1978; 38. (11 Pt 1): 3751-3757. (Pubitemid 9045201)
34. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn 1992; 194: 209-221.
35. Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R. Comparison of lentiviral vector titration methods. BMC Biotechnol 2006; 6: 34.
36. Funke S, Maisner A, Muhlebach MD, Koehl U, Grez M, Cattaneo R et al. Targeted cell entry of lentiviral vectors. Mol Ther 2008; 16: 1427-1436.
37. Morimoto K, Hooper DC, Carbaugh H, Fu ZF, Koprowski H, Dietzschold B. Rabies virus quasispecies: implications for pathogenesis. Proc Natl Acad Sci USA 1998; 95: 3152-3156. (Pubitemid 28135870)
38. Ubeda-Banon I, Novejarque A, Mohedano-Moriano A, Pro-Sistiaga P, de la Rosa-Prieto C, Insausti R et al. Projections from the posterolateral olfactory amygdala to the ventral striatum: neural basis for reinforcing properties of chemical stimuli. BMC Neurosci 2007; 8: 103.
39. Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M. Continuous hightiter HIV-1 vector production. Nat Biotechnol 2003; 21: 569-572. (Pubitemid 36532025)
40. Lesch HP, Turpeinen S, Niskanen EA, Mahonen AJ, Airenne KJ, Yla-Herttuala S. Generation of lentivirus vectors using recombinant baculoviruses. Gene Therapy 2008; 15: 1280-1286.
41. Lesch HP, Laitinen A, Peixoto C, Vicente T, Makkonen KE, Laitinen L et al. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Therapy 2011; 18: 531-538.
42. Hoffmann M, Wu YJ, Gerber M, Berger-Rentsch M, Heimrich B, Schwemmle M et al. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J Gen Virol 2010; 91 (Pt 11): 2782-2793.
43. DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL, Jolly DJ et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000; 2: 218-222.
44. Pichlmair A, Diebold SS, Gschmeissner S, Takeuchi Y, Ikeda Y, Collins MK et al. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol 2007; 81: 539-547. (Pubitemid 46067881)
45. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77: 61-68. (Pubitemid 19125654)
46. Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 2002; 346: 454-465. (Pubitemid 41103153)
47. Pfeifer A, Brandon EP, Kootstra N, Gage FH, Verma IM. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA 2001; 98: 11450-11455. (Pubitemid 32928749)
48. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc 2009; 4: 495-505.
49. Lamikanra A,Myers KA, Ferris N, Mitrophanous KA, Carroll MW. In vivo evaluation of an EIAV vector for the systemic genetic delivery of therapeutic antibodies. Gene Therapy 2005; 12: 988-998. (Pubitemid 40903421)